Eureka Therapeutics
Biotechnology company focuses on an immunotherapies for the treatment of cancer.
Launch date
Employees
Market cap
-
Enterprise valuation
€164—245m (Dealroom.co estimates Mar 2020.)
Emeryville California (HQ)
Authorizing premium user...